Sandostatin LAR 30 mg (Octreotide) by Novartis.
Indications: Acromegaly; symptoms of functional gastro-entero-pancreatic neuroendocrine tumours (carcinoid, VIPomas); advanced midgut NETs.
Administration: Deep intragluteal injection every 4 weeks by a healthcare professional.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Novartis |
| Active ingredient | Octreotide (as acetate) 30 mg — long-acting somatostatin analogue. |
| Strength & pack | 1 vial powder + pre-filled syringe of solvent, with vial adapter and needle. |
| Form | Powder and solvent for suspension for injection |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |